DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding DiaMedica Therapeutics Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 57 | 58 | +1 |
| Shares | 7.51M | 8.76M | +1.25M (+16.6%) |
| Value | $28.5M | $34.2M | +$5.70M (+20.0%) |
New holders (21)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 60,065 | $234.3K | 0.00% |
| Perigon Wealth Management, LLC | 53,000 | $206.7K | 0.00% |
| Nuveen, LLC | 34,347 | $134.0K | 0.00% |
| New York State Common Retirement Fund | 26,300 | $102.6K | 0.00% |
| Rhumbline Advisers | 23,894 | $93.2K | 0.00% |
| Jones Financial Companies LLLP | 16,622 | $63.8K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 14,425 | $56.3K | 0.00% |
| Intech Investment Management LLC | 14,415 | $56.2K | 0.00% |
| Invesco Ltd. | 13,885 | $54.2K | 0.00% |
| Price T Rowe Associates Inc | 13,368 | $53.0K | 0.00% |
| JPMorgan Chase & Co | 12,483 | $48.7K | 0.00% |
| STRS Ohio | 7,600 | $29.6K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 7,441 | $29.0K | 0.00% |
| Truvestments Capital LLC | 4,012 | $15.6K | 0.00% |
| Legal & General Group Plc | 2,943 | $11.5K | 0.00% |
| Ameritas Investment Partners, Inc. | 2,697 | $10.5K | 0.00% |
| California State Teachers Retirement System | 1,648 | $6.43K | 0.00% |
| Amalgamated Bank | 902 | $4.00K | 0.00% |
| Legend Financial Advisors, Inc. | 1,000 | $3.90K | 0.00% |
| Group One Trading, L.P. | 121 | $472 | 0.00% |
| Sterling Capital Management LLC | 64 | $250 | 0.00% |
Sold out (20)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Millennium Management LLC | 336,880 | $1.28M |
| Jane Street Group, LLC | 100,669 | $381.5K |
| HRT Financial LP | 56,703 | $214.0K |
| Citadel Advisors LLC | 53,700 | $203.5K |
| Qube Research & Technologies Ltd | 36,929 | $140.0K |
| Jain Global LLC | 27,679 | $104.9K |
| Jefferies Financial Group Inc. | 26,000 | $98.5K |
| Balyasny Asset Management LLC | 25,270 | $95.8K |
| Omers Administration Corp | 24,300 | $92.1K |
| Schonfeld Strategic Advisors LLC | 16,483 | $62.5K |
| LMR Partners LLP | 15,167 | $57.5K |
| ExodusPoint Capital Management, LP | 13,343 | $51.0K |
| Y-Intercept (Hong Kong) Ltd | 13,335 | $50.5K |
| Point72 Asia (Singapore) Pte. Ltd. | 12,480 | $47.3K |
| Diametric Capital, LP | 12,423 | $47.1K |
| SG Americas Securities, LLC | 10,878 | $41.0K |
| Cubist Systematic Strategies, LLC | 3,209 | $12.2K |
| Tower Research Capital LLC (TRC) | 738 | $2.80K |
| Point72 (DIFC) Ltd | 642 | $2.43K |
| Simplex Trading, LLC | 374 | $1.00K |